Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Abstract Full Text (PDF, 341K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Zimmer, J. Articles by Held, W. Search for Related Content PubMed PubMed Citation Articles by Zimmer, J. Articles by Held, W. Social Bookmarking                            What's this?

Original Article

Jacques Zimmer, Vassilios Ioannidis and Werner Held

Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, 1066 Epalinges, Switzerland

Address correspondence to Werner Held, Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Ch. des Boveresses 155, 1066 Epalinges, Switzerland. Phone: 4121-692-5958; Fax: 4121-653-4474; E-mail: wheld{at}isrec.unil.ch

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
To study the adaptation of natural killer (NK) cells to their major histocompatibility complex (MHC) class I environment we have established a novel mouse model with mosaic expression of H-2D^d using a Cre/loxP system. In these mice, we noticed that NK cells expressing the inhibitory receptor for D^d, Ly49A, were specifically underrepresented among cells with low D^d levels. That was due to the acquisition of D^d molecules by the Ly49A⁺ NK cells that have lost their D^d transgene. The uptake of H-2D molecules via the Ly49A receptor was restricted to strong ligands of Ly49A. Surprisingly, when Ly49A⁺ NK cells were D^d+, uptake of the alternative ligand D^k was not detectable. Similarly, one anti-Ly49A mAb (A1) bound inefficiently when Ly49A was expressed on D^d+ NK cells. Concomitantly, functional assays demonstrated a reduced capacity of Ly49A to inhibit H-2^bD^d as compared with H-2^b NK cells, rendering Ly49A⁺ NK cells in D^d+ mice particularly reactive. Minor reductions of D^d levels and/or increases of activating ligands on environmental cells may thus suffice to abrogate Ly49A-mediated NK cell inhibition. The mechanistic explanation for all these phenomena is likely the partial masking of Ly49A by D^d on the same cell via a lateral binding site in the H-2D^d molecule.

Key Words: ligand uptake • NK cells • Ly49A • H-2D • Cre/loxP

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
NK cells are lymphocytes capable of killing various tumor and virally infected target cells and produce cytokines (in particular IFN-) and chemokines (1). An inverse correlation exists between the expression levels of MHC class I molecules on potential target cells and their susceptibility to NK cell–mediated lysis, a pattern termed missing self-recognition (2). Normal levels of MHC class I molecules expressed by normal cells prevent lysis by autologous NK cells. Reduced expression or loss of MHC class I molecules and/or increased expression of ligands for activating NK cell receptors, which can occur upon malignant transformation or viral infection, will abrogate NK cell inhibition and lead to target cell lysis (3–5).

NK cells express inhibitory receptors that preclude NK cell reactivity upon recognition of MHC class I molecules on target cells. In the mouse, inhibitory receptors specific for MHC class Ia molecules belong to the Ly49 receptor family (for review, see references 6 and 7). Some of these C-type lectin-like receptors are able to discriminate polymorphic MHC class Ia molecules. For example, the inhibitory Ly49A receptor interacts strongly with class I molecules such as H-2D^d (D^d) and D^k, but only very weakly with D^b (8–10). The selectivity of some Ly49 receptors together with their combinatorial distribution allows NK cells to react to subtle changes in a cell's MHC make up, such as the absence of a single class I allele (11).

The MHC class I environment in which NK cells arise influences their reactivity to target cells. NK cells do not reject syngeneic bone marrow grafts, e.g., H-2^b mice accept H-2^b grafts. However, upon the expression of a D^d transgene (Tg)^*in H-2^b mice, NK cells acquire the capacity to reject bone marrow grafts from H-2^b donors, while they are unreactive to syngeneic H-2^bD^d grafts (12, 13). NK cells adapt to the presence of the Tg D^d molecule, acquiring tolerance toward MHC-identical (D^d+) cells and reactivity to cells that lack D^d, a pattern we have termed missing D^d-reactivity. Self-tolerance of H-2^bD^d Ly49A⁺ NK cells is indeed ensured via the inhibitory effect of Ly49A. In contrast, the analysis of H-2^b Ly49A⁺ NK cells revealed that self-tolerance was independent of Ly49A function. (14–16).

The cellular and molecular basis for the NK cells adaptation to their MHC class I environment is still not well understood. To study these processes we have engineered a genetic "off-switch" for D^d using an inducible Cre/loxP system (13). D^d Tg mice were generated using a genomic D^d clone, which is flanked by loxP sites. The loxP sites can be recognized by Cre recombinase, leading to the deletion of the flanked sequence and consequently shutdown of D^d expression. These D^d Tg mice were crossed to mice harboring a Cre Tg that is under the control of the IFN- responsive Mx promoter (17). Lymphocytes in D^d x MxCre double Tg mice displayed variable D^d levels even without deliberate Cre induction (13). In these and other mice with mosaic expression of a D^d Tg, i.e., where in individual mice H-2^bD^d and H-2^b cells coexist, NK cells failed to appropriately acquire missing-D^d reactivity (13, 18). Missing-D^d reactivity in D^d single Tg mice is performed by Ly49A-expressing NK cells (14). In the D^d mosaic situation these cells failed to acquire missing-D^d reactivity (13).

To explore the basis for the differential behavior of Ly49A⁺ NK cells we have compared the Ly49A⁺ NK cell subsets of B6 (H-2^b), D^d single (H-2^bD^d), and D^d x MxCre double Tg mice. During these analyses we have noticed that in D^d x MxCre double Tg mice only very few Ly49A⁺ NK cells were devoid of D^d. We show that this is due to an ability of the Ly49A NK cell receptor to acquire D^d molecules from environmental D^d-expressing cells. Interestingly, however, H-2 ligand expression by Ly49A⁺ NK cells prevented ligand uptake from environmental cells. Further experiments suggested that the Ly49A receptor in D^d+ mice is poorly accessible and concomitantly that the capacity of Ly49A to signal NK cell inhibition is drastically reduced. These findings and their implications for NK cell function are discussed in the context of the recent resolution of the crystallographic structure of the Ly49A/H-2D^d complex (19).

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Mice.
C57BL/6 (B6) (CD45.2, H-2^b), B10.D2 (H-2^d), and B10.BR (H-2^k) mice were purchased from Harlan OLAC. Congenic B6 CD45.1 and ß2-microglobulin (ß2m)-deficient B6 mice were purchased from The Jackson Laboratory. Ly49A Tg mice were described previously (20). Floxed D^d Tg mice, backcrossed to B6 mice, were described elsewhere (13). Mx1-Cre Tg mice were provided by M. Aguet, Institut Swisse De Recherche Experimentale Sur Le Cancer, Epalinges, Switzerland (17). All mice were older than 6 wk when used for experiments.

Cre expression was induced by intraperitoneal injection of the IFN-inducer polyinosinic-polycytidylic acid (polyI/C; Sigma-Aldrich). Mice received 250 µg polyI/C intraperitoneal (diluted in PBS) on days 0, 2, and 4. Control mice received PBS. The lymphoid organs were analyzed 10 d after the last injection.

Antibodies and Flow Cytometry.
Cell suspensions (usually 10⁶ cells per sample) were incubated with 24G2 (anti-CD16/32) hybridoma culture supernatant to reduce background. For surface stainings, the following mAbs were obtained from BD PharMingen unless otherwise indicated: 34–2-12 (anti-H-2D^d), 34–4-20S (anti-H-2D^d, obtained from American Type Culture Collection), 15–5-5 (anti-H-2D^k), KH95 (anti-H-2D^b), JR9–318 (anti-Ly49A [reference 21], provided by J. Roland, Institut Pasteur, Paris, France), A1 (anti-Ly49A^B6), YE1–48 (anti-Ly49A [reference 22], provided by F. Takei, University of British Columbia, Vancouver, Canada), 5E6 (anti-Ly49C/I), 4D11 (anti-Ly49G2), 4E5 (anti-Ly49D), 145–2C11 (anti-CD3), PK136 (anti-NK1.1), RA3–6B2 (anti-CD45R/B220), A20 (anti-CD45.1), and 104 (anti-CD45.2). These mAbs were used either biotinylated or conjugated to different fluorochromes (FITC, PE, Cy-Chrome^TM [Cy], Cy 5, allophycocyanin [APC]) to allow three or four color flow cytometry. Biotinylated mAbs were revealed through staining with either streptavidin-Cy (BD PharMingen) or streptavidin-APC (Molecular Probes). The samples were analyzed on a FACSCalibur^TM flow cytometer (Becton Dickinson) using CELLQuest^TM software (Becton Dickinson) for data evaluation.

Mixed Bone Marrow Chimeras.
Recipient mice were injected intraperitoneally with 100 µg of purified PK136 mAb (anti-NK1.1) to deplete NK cells. They were lethally irradiated 24 h later (960 rad from a ¹³⁷Cs source). 1 d after the irradiation, the recipient mice were reconstituted by intravenous injection of a 1:1 mixture of Thy-1–depleted bone marrow cells from B6 and H-2^bD^d mice (10⁶ cells from each donor type). Antibiotics were added to the drinking water during the first 4 wk after reconstitution.

In Vitro Uptake of MHC Class I Molecules.
Total, erythrocyte-depleted splenocytes from two mice with different MHC haplotypes (2 x 10⁶ cells of either type) were mixed, centrifuged, and resuspended in 1 ml of culture medium.

After 2 h at 37°C, the cells were washed in culture medium and then stained for flow cytometry as described previously. For Ab-blocking studies, the cells were mixed and resuspended (without the initial centrifugation step) in 1 ml of culture medium, 1 ml of 34–4-20S (anti-D^d) hybridoma culture supernatant, or 10 µg of purified A1 (anti–Ly49A^B6) in 1 ml of culture medium. Stainings were performed with mAbs specific for epitopes that are different from those used for blocking: 34–2-12 for D^d and JR9–318 for Ly49A.

NK Cell Culture.
Nylon wool nonadherent splenocytes were cultured in complete DMEM supplemented with 10% FCS, L-glutamine, Hepes buffer, ß2-mercaptoethanol, and penicillin/streptomycin (all from Life Technologies) containing 500 ng/ml of recombinant human IL-2 (a gift from Glaxo IMB). The cells were incubated at 37°C at a density of 2 x 10⁶ cells per milliliter in a total volume of 10 ml/flask. At day 3, cells were either used for cytotoxicity assays or adherent cells were restimulated for 7 more days with fresh medium containing IL-2.

Chromium Release Assays.
To determine cytotoxic activities, a conventional ⁵¹Cr-release assay was performed. Briefly, 10⁶ C1498 or D^d transfected C1498 cells (provided by W. Seaman, University of California at San Francisco, San Francisco, CA) were labeled with 50 µCi of ⁵¹Cr for 1 h at 37°C. After three washes, 5 x 10³ labeled target cells were mixed with effector cells in duplicate at various E:T ratios in 96-well U-bottomed plates. After 4 h of incubation at 37°C, supernatants were harvested and radioactivity was measured in a -counter. The percentages of NK cells (NK1.1⁺CD3^-) in the effector cell cultures were determined using flow cytometry. The lysis curves were shifted relative to the content of NK cells in the B6 effector cell population.

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Heterogeneous Expression of D^d in D^d x MxCre Double Tg Mice.
Lymphocytes in D^d single Tg mice, backcrossed to B6 mice (i.e., being H-2^bD^d) homogeneously expressed high levels of D^d (Fig. 1 a). In contrast, heterogeneous D^d expression with high, intermediate, and low D^d levels was observed in lymphocytes from unmanipulated D^d x MxCre double Tg mice (Fig. 1 a). Expression levels of D^d on the D^d high lymphocytes were similar to those in D^d single Tg mice. The D^d intermediate population may represent cells with a partial recombination of the multicopy Tg locus. In individual mice, the fraction of D^d low cells was comparable among NK, T, B, and NK T cells of several organs (spleen, bone marrow, peripheral blood) (Fig. 1 b and data not shown). With increasing age of the mice also the fraction of D^d low cells increased (data not shown).

View larger version (33K): [in this window] [in a new window]   Figure 1. Heterogeneous Dd Tg expression in Dd x MxCre double Tg mice. (a) Histograms show Dd expression on splenocytes from nonTg (H-2b) (left), Dd single Tg (H-2bDd) (middle), and Dd x MxCre double Tg (right) mice. Numbers in histograms indicate the percentages of splenocytes with low, intermediate, and high Dd expression, respectively. (b) Histograms show Dd expression on splenic NK cells (NK1.1+CD3-), T cells (NK1.1-CD3+), and B cells (CD45R/B220+) of a representative Dd x MxCre double Tg mouse. Numbers in histograms indicate the percentages of splenocytes with low, intermediate, and high Dd expression, respectively. A comparable Dd distribution was found in all Dd x MxCre mice analyzed, even though the percentages of Dd low cells varied and tended to increase with age.

Ly49A⁺ Cells Are Underrepresented among D^d Low NK Cells of D^d x MxCre Mice.
The partial loss of D^d expression had no significant effect on the abundance of NK cells in spleen and in bone marrow (data not shown). Since NK cells themselves were D^d high, intermediate, and low, we determined whether Ly49 receptors were equally abundant in the different populations. No differences were observed regarding the expression of Ly49C/I (Fig. 2), Ly49G2, or Ly49D (data not shown). Unexpectedly, Ly49A was expressed on few (6 ± 3%) D^d low NK cells, contrasting with a relatively normal percentage of expression on D^d high NK cells (22 ± 5%; Fig. 2). However, an expanded population of Ly49A⁺ cells was detected among NK cells with intermediate D^d levels (32 ± 7%; Fig. 2). Yet, the fraction of Ly49A⁺ cells among total NK cells of D^d x MxCre mice (18 ± 3%) was in the same range as that of nonTg H-2^b (18 ± 3%) or D^d Tg mice (16 ± 2%). These results suggest that Ly49A⁺ NK cells are somehow more resistant to complete D^d loss compared with Ly49A^- NK cells.

View larger version (43K): [in this window] [in a new window]   Figure 2. Reduced presence of Ly49A+ NK cells with low Dd levels. Splenocytes from representative non Tg (H-2b), Dd single Tg (H-2bDd), and Dd x MxCre double Tg mice were stained with mAbs to Ly49A or Ly49C/I, NK1.1, CD3, and Dd and analyzed by four color flow cytometry. (a) NK cells (NK1.1+CD3-) were gated among total splenocytes and analyzed for Ly49A and Ly49C/I expression. Numbers indicate the percentages of Ly49A+ (top histograms) and Ly49C/I+ (bottom histograms) cells among NK cells from the indicated types of mice. The expression levels of Ly49A and Ly49C/I are indicated as MFI. (b) Gated NK cells (NK1.1+CD3-) from a representative Dd x MxCre double Tg mouse were subdivided according to Dd expression into Dd low, intermediate, and high cells. Numbers indicate the percentages of Ly49A+ (top histograms) and Ly49C/I+ cells (lower histograms) among the different NK cell subpopulations. The expression levels of Ly49A and Ly49C/I are indicated as MFI. (c) The density plots show expression of Ly49A (left) and Ly49C/I (right) versus Dd on splenic NK cells (NK1.1+CD3-) from a Dd x MxCre mouse.

Among possible mechanisms that could account for these findings, Ly49A⁺ NK cells may be resistant to complete D^d recombination, perhaps due to an inactivity of the Mx promoter in these cells. To address this possibility we enforced D^d recombination in vivo by inducing Cre expression. 10 d after the last intraperitoneal injection with the IFN-inducer polyI/C, >86% of D^d x MxCre splenocytes were D^d low (data not shown). A comparable fraction (89%) of D^d low cells was observed among NK cells that do not express Ly49A (Fig. 3 a). In contrast, Ly49A⁺ NK cells still contained significant amounts of D^d, as only 54% of cells were in the D^d low gate (Fig. 3 a). After the culture of nylon wool nonadherent cells in IL-2 for 10 d however, essentially all (98%) Ly49A⁺ NK cells were D^d low (Fig. 3 b). Thus, the complete loss of D^d expression among cultured Ly49A⁺ NK cells indicates that these cells too had recombined their D^d Tg. However, the ex vivo analysis suggests that D^d disappears slowly from Ly49A⁺ NK cells when compared with Ly49A^- NK cells or lymphocytes.

View larger version (37K): [in this window] [in a new window]   Figure 3. Enforced deletion of the Dd Tg in Dd x MxCre mice. Histograms show Dd expression on NK cells from control PBS-injected Dd x MxCre (left), polyI/C injected Dd x MxCre (middle), and polyI/C injected Dd single Tg mice (right). Freshly isolated nylon-wool nonadherent splenocytes (a) or cultures established thereof (10 d in IL-2 containing medium) (b) were stained with mAbs to Ly49A, NK1.1, CD3, and Dd and analyzed by four color flow cytometry. Ly49A- (top) and Ly49A+ (bottom) NK cells (NK1.1+CD3-) were separately analyzed for Dd expression. Numbers in histograms indicate the percentages of NK cells with low Dd expression.

Hematopoietic chimerism in recipient mice was analyzed 2–4 mo after reconstitution through staining with anti-CD45.1 and anti-CD45.2 mAbs. 33% of lymphocytes in spleen (Fig. 4 a), blood and bone marrow (data not shown) were CD45.1⁺ and thus of B6 origin. When splenic NK cells were discriminated through CD45 expression, a normal percentage (18–20%) of Ly49A⁺ cells was identified among CD45.1⁺ (H-2^b) and CD45.1^- (H-2^bD^d) cells (Fig. 4 a). However, CD45.1⁺ NK cells (of B6 origin) appeared as D^d intermediate cells (Fig. 4 b). As these cells are genetically D^d-deficient, our findings imply that they have acquired D^d molecules from environmental D^d+ cells in vivo. Similarly, Ly49A⁺ NK cells that have recombined their D^d Tg in the D^d x MxCre situation may thus take up D^d from environmental D^d+ cells and appear as D^d intermediate cells.

View larger version (32K): [in this window] [in a new window]   Figure 4. Uptake of Dd molecules by Ly49A+ NK cells in vivo. Lethally irradiated H-2bDd (CD45.2+) recipients were reconstituted with a 1:1 mixture of bone marrow cells from B6 (CD45.1+) and H-2bDd (CD45.2+) mice and spleens analyzed 2–4 mo after reconstitution. The data shown are representative of three different experiments with similar results. (a) Nylon wool nonadherent splenocytes from a mixed bone marrow chimera were stained with mAbs to Ly49A, NK1.1, CD3, and CD45.1 and analyzed by four color flow cytometry. Ly49A expression was analyzed among CD45.1+ (B6) and CD45.1- (H-2bDd) NK cells. Numbers correspond to the percentages of Ly49A+ NK cells and the expression levels of Ly49A (MFI). (b) Density plots show expression of Ly49A versus Dd on splenic NK cells (NK1.1+CD3-) (left), Ly49A versus Dd on gated CD45.1+ (H-2b-derived) NK1.1+ splenocytes (middle), and Ly49A versus Dd on gated CD45.2+ (H-2bDd-derived) NK1.1+ splenocytes (right) from a representative mixed chimera.

H-2D Ligand Uptake via the Ly49A Receptor In Vitro.
To obtain further evidence that D^d molecules can be acquired by Ly49A⁺ NK cells, we mixed splenocytes from B6 (H-2^b) mice with splenocytes from D^d Tg or from B10.D2 (H-2^d) mice. The cells were mixed and incubated at 37°C for 2 h before staining and FACS^® analysis. Indeed, Ly49A⁺ NK cells from B6 mice became significantly D^d+ (Fig. 5 a). The transfer of D^d molecules was completely blocked by the addition of either the anti-D^d mAb 34–4-20S (Fig. 5 a) or the anti-Ly49A mAb A1 (data not shown) demonstrating that H-2D^d uptake is dependent on the Ly49A receptor. In agreement with the in vivo data, the majority of Ly49C/I⁺, Ly49G2⁺, and Ly49D⁺ NK cells from B6 mice remained D^d low (data not shown).

View larger version (27K): [in this window] [in a new window]   Figure 5. Specificity of uptake of H-2D alleles in vitro. (a) Total splenocytes from B6 (H-2b) and B10.D2 (H-2d) mice were mixed and incubated for 2 h at 37°C. The expression of Ly49A versus Dd among gated NK cells (NK1.1+CD3-) is shown for B6 (top left) and B10.D2 cells (top right). Mixed populations of B6 plus B10.D2 cells were left untreated (bottom left) or incubated with an anti-Dd mAb (34–4-20S) (bottom right). (b) Total splenocytes from MHC class I–deficient (ß2m-/-), B6 (H-2b), Dd single Tg (H-2bDd), B10.D2 (H-2d), or B10.BR (H-2k) mice were mixed in various combinations and stained with mAbs to Dd, Dk, or Db together with mAbs to Ly49A, CD3, and NK1.1. Expression of Ly49A versus Dd, Dk, or Db was analyzed among Ly49A+ NK cells (NK1.1+CD3-). The MFI of H-2D alleles on Ly49A+ NK cells expressing the respective gene was arbitrarily assigned the value 100 (R1 in a). The extent of uptake of the H-2D alleles by Ly49A+ NK cells was determined by the MFI in R2 and indicated as a percentage of R1. The MFI of the H-2D allele on Ly49A+ NK cells that do not express the respective gene and that were not mixed with other cells represents the background staining. Data show means (± SD) of usually three or more independent experiments.

H-2D Ligand Expression by Ly49A⁺ NK Cells Prevents Ligand Uptake.
We further investigated whether Ly49A⁺ NK cells expressing themselves a ligand for Ly49A (D^d or D^k), are able to acquire a ligand from environmental cells. For this purpose, we mixed splenocytes from H-2^d mice with those from H-2^k mice. Interestingly, the acquisition of D^d by H-2^k Ly49A⁺ NK cells as well as the acquisition of D^k by H-2^d Ly49A⁺ NK cells was very low to undetectable (Fig. 5 b). In contrast, Ly49A⁺ NK cells from H-2^b mice efficiently took up D^d as well as D^k (Fig. 5 b).

To confirm the relative absence of H-2D ligand uptake from environmental cells in the presence of a ligand on Ly49A⁺ NK cells, we crossed D^d x MxCre mice to B10.BR (H-2^k) mice. In control D^d x MxCre mice (H-2^b/b background), we observed significantly fewer D^d low Ly49A⁺ as compared with Ly49A^- NK cells (Fig. 6), consistent with D^d uptake via Ly49A. In contrast, in D^d x MxCre mice of H-2^k/b background, the fraction of D^d low cells was similar among Ly49A⁺ and Ly49A^- NK cells (Fig. 6). These findings suggest that D^d uptake by Ly49A did not occur. They corroborate the in vitro results and suggest that H-2 ligand uptake from environmental cells does not detectably occur when a H-2 ligand is expressed on Ly49A⁺ NK cells.

View larger version (41K): [in this window] [in a new window]   Figure 6. H-2k expression prevents Dd uptake in vivo. Splenocytes from H-2b/b Dd x MxCre and H-2b/k Dd x MxCre double Tg mice were stained with mAbs to Ly49A, NK1.1, CD3, and Dd and analyzed by four color flow cytometry. (a) Histograms show Dd expression on Ly49A- (top) and Ly49A+ (bottom) NK cells (NK1.1+CD3-) of the two types of mice. Numbers in histograms indicate the percentages of NK cells with low Dd expression. (b) Density plots show expression of Ly49A versus Dd on gated NK cells (NK1.1+CD3-) from the two types of mice.

View larger version (33K): [in this window] [in a new window]   Figure 7. Reduced binding of mAb A1 to Ly49A on Dd+ NK cells. Splenocytes from B6 (H-2b) and B10.D2 (H-2d) mice were stained with mAbs to NK1.1 and CD3 together with the indicated anti-Ly49A mAbs (JR9, YE1–48, or A1), and analyzed by flow cytometry. Histograms show anti-Ly49A stainings using the indicated mAb among gated NK cells (NK1.1+CD3-). Numbers indicate percentages of gated Ly49A+ NK cells and the MFI of Ly49A expression. Numbers in brackets express the MFI as a percentage of the one obtained for Ly49A+ NK cells from B6 mice (=100).

View larger version (17K): [in this window] [in a new window]   Figure 8. Inefficient inhibition of Dd+ NK cells by Ly49A. Short-term (3 d) IL-2–activated NK cells were generated from Ly49A single Tg (H-2b) (black squares), Dd single Tg (H-2bDd) (white circles), and Dd x Ly49A double Tg (H-2bDd) (black triangles) mice. Cytotoxic activity of these preparations to the tumor cell line C1498 (H-2b) and Dd-transfected C1498 (C1498 Dd) was tested in a standard 4-h Cr release assay.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

The uptake of class I molecules by Ly49A⁺ NK cells resembles the acquisition of target cell molecules by other lymphocyte populations. CD8⁺ T lymphocytes rapidly acquire specific peptide–MHC class I complexes from APC (28–30). This acquisition is mediated through the TCR and strictly depends on the presence of the appropriate peptide/MHC class I complex. Furthermore, CD8⁺ and CD4⁺ T cells acquire, specifically through the CD28 costimulatory molecule, CD80 from APC (29, 31). Similarly, B cells can take up specific membrane-bound antigens via their BCR (32). Although mediated through specific TCR–MHC, CD28–CD80, or BCR–antigen interactions, the acquisition is often not limited to these particular ligands but extends to various other cell surface molecules, as entire membrane fragments may be transferred from APC to T cells (30). In most of these situations, the resulting complexes are rapidly internalized and degraded (28, 29, 32). It seems thus likely that also in NK cells Ly49A–D^d complexes are subject to internalization and degradation.

Unexpectedly, when NK cells expressed D^d, the Ly49A-mediated acquisition of D^k, an alternative Ly49A ligand, from environmental cells was very inefficient. H-2 ligand expression by Ly49A⁺ NK cells thus interferes with ligand uptake mediated by Ly49A. It is useful to consider these findings in the context of the recent resolution of the crystallographic structure of the Ly49A/H-2D^d complex (19). This structure revealed the interaction of Ly49A with two distinct sites of D^d. Ly49A interacted with amino terminal residues of the 1 helix and COOH-terminal residues of the 2 helix of D^d (site 1). The other site is located beneath the floor of the peptide binding groove, making contact with residues of the 2, 3, and ß2m domains (site 2). The relative importance of these two sites (as well as additional residues identified by site directed mutagenesis) for the interaction of Ly49A with D^d on target cells (interaction in trans) has not been resolved (33–37). It is possible that interactions at both sites are required for functional NK cell–target cell interactions. As a surprise, however, in addition to an interaction in trans, site 2 may allow an interaction of D^d with Ly49A on the same cell (cis interaction; reference 19). Therefore, we propose that the uptake of D^d from environmental cells is severely impaired due to an interaction of Ly49A in cis with its D^d ligand.

A number of findings reported here and by others are in agreement with cis effects of D^d on Ly49A. Ly49A levels on NK cells are downmodulated approximately twofold in the presence as compared with the absence of D^d based on antibody stainings (14, 38). Surprisingly, in a D^d+ environment, Ly49A⁺ NK cells which themselves do not express D^d are more susceptible to Ly49A downmodulation than those expressing D^d (Figs. 2 and 4; reference 39). Indeed, D^k expression in cis limited Ly49A downmodulation upon the interaction with D^d in trans (Fig. 6 b).

Historically, Ly49A⁺ NK cells were initially not detectable in H-2^d mice using mAb A1. Indeed, we find that the staining with mAb A1 is at least fivefold less intense than on H-2^b NK cells. That is in contrast to two other mAbs, which yielded twofold reductions. Binding of mAb A1 to its epitope is thus specifically affected by D^d expression on NK cells. The binding of mAb A1 to the carbohydrate recognition domain of Ly49A together with its binding to Ly49A^B6, Ly49A^NOD, and Ly49P^NOD but not to Ly49A^Balb suggests that the A1 epitope depends on a threonine residue on position 138 of Ly49A (40–42). Interestingly, this residue makes contact with site 2 of the D^d molecule (19). A1 binding to Ly49A may thus be inefficient because D^d is associated with Ly49A, thereby masking the A1 epitope.

Along those same lines it was reported that D^d tetramers readily bind to Ly49A on H-2^b NK cells. However, they do apparently not bind well to Ly49A expressed on H-2^d NK cells (10, 43). This was explained in principal by the (twofold) reduced levels of Ly49A on NK cells from H-2^d compared with those from H-2^b mice (based on mAb stainings) having a critical threshold effect obliterating tetramer staining. However, soluble Ly49A reagents readily interacted with D^d expressed on various lymphocyte populations (44–46). This apparent discrepancy is readily resolved if H-2 ligand expression by Ly49A receptor bearing NK cells renders Ly49A interactions with D^d ligands encountered in trans inefficient. Therefore, collectively there is ample evidence that D^d expression by Ly49A⁺ NK cells alters the accessibility of the Ly49A receptor. These findings are all compatible with an association in cis of D^d with Ly49A. We are currently attempting to obtain direct evidence for such an association.

Is ligand loss from or ligand uptake by Ly49A⁺ NK cells of functional relevance? First, we have considered the possibility that the loss of the D^d gene by Ly49A⁺ NK cells, which may terminate a cis interaction, is relevant for the survival of these NK cells. Indeed, it has been shown that the Cre/loxP–mediated loss of surface Igs (BCR) on mature B cells leads to their rapid apoptotic death, suggesting that the BCR provides survival signals to B cells (47). A similar survival signal provided to NK cells through Ly49A–D^d interactions in our model seems unlikely, since the fraction of Ly49A⁺ cells among total NK cells was not reduced in D^d x MxCre mice. In addition, even the enforced deletion of D^d using polyI/C treatment of D^d x MxCre mice, did not negatively affect the number of Ly49A⁺ NK cells. Although it could be argued that in D^d x MxCre mice Ly49A⁺ NK cells are never completely devoid of D^d.

A role of H-2 ligand uptake in vivo is not immediately obvious, especially since it seems to efficiently occur only in exceptional cases such as a class I mosaic situation. It is also worth to point out that in contrast to T cells, the functional consequence of an interaction that results in ligand uptake, is NK cell inhibition and not cellular activation. One could thus envisage two roles for ligand uptake: first it may facilitate the detachment from target cells and/or ligand uptake could participate in inhibitory signaling perhaps once the complex has been internalized (48). Indeed, Ly49A-mediated ligand uptake correlates with efficient NK cell inhibition in H-2^b NK cells.

While the above issues remain to be addressed, the relative absence of ligand uptake by Ly49A has prompted us to reevaluate the accessibility and function of Ly49A on D^d+ NK cells. Indeed, the inhibitory capacity of the Ly49A receptor on H-2^bD^d NK cells was considerably reduced as compared with H-2^b NK cells. D^d+ tumor target cells that inhibited lysis by Ly49A⁺ NK cells from H-2^b mice were readily killed by Ly49A⁺ NK cells from H-2^bD^d mice (Fig. 8; references 14 and 27). The latter NK cells are thus more sensitive to increases in activation signals and/or subtle reductions in D^d levels. Previously, this effect has been attributed to the approximately twofold lower levels of Ly49A on H-2^d as compared with H-2^b NK cells. However, our results suggest that the inhibitory capacity of Ly49A on H-2^d NK cells is at least 10-fold reduced as compared with H-2^b NK cells (Fig. 8). Based on these findings it is conceivable that it is the limited accessibility of Ly49A due to D^d expression in cis, which renders D^d+ Ly49A⁺ NK cells particularly sensitive to detect subtle alterations in D^d expressing environmental cells. Hence, D^d expression in cis may be important to establish the fine specificity of Ly49A⁺ NK cells.

Collectively, we provide evidence that H-2 ligand expression by NK cells significantly affects the behavior of the inhibitory Ly49A NK cell receptor. Ligand expression by NK cells drastically reduces the accessibility of Ly49A to ligands encountered in trans, on environmental cells. Reduced accessibility may be responsible for the increased sensitivity of the Ly49A receptor in D^d+ NK cells. Small reductions of D^d levels and/or increases of ligands for activating receptors on target cells are sufficient to abrogate Ly49A-mediated NK cell inhibition, allowing target cell lysis to proceed.

	Acknowledgments

 
We thank F. Beermann for Tg injections, M. Aguet for providing Mx1-Cre Tg mice, J. Roland, and F. Takei for providing mAbs, W. Seaman for providing C1498 cells and J.-C. Cerottini for critical reading of the manuscript.

W. Held is the recipient of a START fellowship and supported in part by a grant from the Swiss National Science Foundation.

Submitted: August 22, 2001
Accepted: October 12, 2001

	Footnotes

 
^* Abbreviations used in this paper: APC, allophycocyanin; MFI, mean fluorescence intensity; polyI/C, polyinosinic-polycytidylic acid; Tg, transgenic/transgene.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1 Biron, C.A., K.B. Nguyen, G.C. Pien, L.P. Cousens, and T.P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189–220.[Abstract/Full Text]

2 Ljunggren, H.G., and K. Kärre. 1990. In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol. Today. 11:237–244.[Medline]

3 Lanier, L.L., B. Corliss, and J.H. Phillips. 1997. Arousal and inhibition of human NK cells. Immunol. Rev. 155:145–154.[Medline]

4 Cerwenka, A., A.B.H. Bakker, T. McClanahan, J. Wagner, J. Wu, J.H. Phillips, and L.L. Lanier. 2000. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity. 12:721–727.[Medline]

5 Diefenbach, A., A.N. Jamieson, S. Liu, N. Shastri, and D.H. Raulet. 2000. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1:95–97.[Medline]

6 Lanier, L.L. 1998. NK cell receptors. Annu. Rev. Immunol. 16:359–393.[Abstract/Full Text]

7 Long, E.O. 1999. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17:875–904.[Abstract/Full Text]

8 Karlhofer, F.M., R.K. Ribaudo, and W.M. Yokoyama. 1992. MHC class I alloantigen specificity of Ly-49⁺ IL-2 activated natural killer cells. Nature. 358:66–70.[Medline]

9 Kane, K. 1994. Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules. J. Exp. Med. 179:1011–1015.[Abstract]

10 Hanke, T., H. Takizawa, C.W. McMahon, D.H. Busch, E.G. Pamer, J.D. Miller, J.D. Altman, Y. Liu, D. Cado, F.A. Lemonnier, et al. 1999. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity. 11:67–77.[Medline]

11 Raulet, D.H., R.E. Vance, and C.W. McMahon. 2001. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19:291–330.[Medline]

12 Ohlen, C., G. Kling, P. Höglund, M. Hansson, G. Scangos, C. Bieberich, G. Jay, and K. Karre. 1989. Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science. 246:666–668.[Medline]

13 Ioannidis, V., J. Zimmer, F. Beermann, and W. Held. 2001. Cre recombinase-mediated inactivation of H-2Dd transgene expression: evidence for partial missing-self recognition by Ly49A NK cells. J. Immunol. In press.

14 Olsson, M.Y., K. Karre, and C.L. Sentman. 1995. Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand. Proc. Natl. Acad. Sci. USA. 92:1649–1653.[Abstract]

15 Dorfman, J.R., and D.H. Raulet. 1996. Major histocompatibility complex genes determine natural killer cell tolerance. Eur. J. Immunol. 26:151–155.[Medline]

16 Yu, Y.Y., T. George, J. Dorfman, J. Roland, V. Kumar, and M. Bennett. 1996. The role of Ly49A and 5E6 (Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. Immunity. 4:67–76.[Medline]

17 Kuhn, R., F. Schwenk, M. Aguet, and K. Rajewsky. 1995. Inducible gene targeting in mice. Science. 269:1427–1429.[Medline]

18 Johansson, M.H., C. Bieberich, G. Jay, K. Kärre, and P. Höglund. 1997. Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I molecules. J. Exp. Med. 186:353–364.[Abstract/Full Text]

19 Tormo, J., K. Natarajan, D.H. Margulies, and R.A. Mariuzza. 1999. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature. 402:623–631.[Medline]

20 Held, W., D. Cado, and D.H. Raulet. 1996. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejction. J. Exp. Med. 184:2037–2041.[Abstract]

21 Roland, J., and P.A. Cazenave. 1992. Ly-49 antigen defines an ß TCR population in i-IEL with an extrathymic maturation. Int. Immunol. 4:699–706.[Abstract]

22 Chan, P.Y., and F. Takei. 1986. Expression of a T cell receptor-like molecule on normal and malignant murine T cells detected by rat monoclonal antibodies to nonclonotypic determinants. J. Immunol. 136:1346–1353.[Abstract]

23 Held, W., and D.H. Raulet. 1997. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. J. Exp. Med. 185:2079–2088.[Abstract/Full Text]

24 Brawand, P., F.A. Lemonnier, H.R. MacDonald, J.C. Cerottini, and W. Held. 2000. Transgenic expression of Ly49A on T cells impairs a specific anti-tumor response. J. Immunol. 165:1871–1876.[Abstract/Full Text]

25 Hoglund, P., J. Sundback, M.Y. Olsson-Alheim, M. Johansson, M. Salcedo, C. Ohlen, H.G. Ljunggren, C.L. Sentman, and K. Karre. 1997. Host MHC class I gene control of NK-cell specificity in the mouse. Immunol. Rev. 155:11–28.[Medline]

26 Deleted in proof.

27 Olsson-Alheim, M.Y., M. Salcedo, H.-G. Ljunggren, K. Kärre, and C.L. Sentman. 1997. NK cell receptor calibration. Effects of MHC class I induction on killing by Ly49A^high and Ly49A^low NK cells. J. Immunol. 159:3189–3194.[Abstract]

28 Huang, J.F., Y. Yang, H. Sepulveda, W. Shi, I. Hwang, P.A. Peterson, M.R. Jackson, J. Sprent, and Z. Cai. 1999. TCR-mediated internalization of peptide-MHC complexes by T cells. Science. 286:952–954.[Abstract/Full Text]

29 Hwang, I., J.F. Huamg, H. Kishimoto, A. Brunmark, P.A. Peterson, M.R. Jackson, C.D. Surh, Z. Cai, and J. Sprent. 2000. T cells can use either T cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen-presenting cells. J. Exp. Med. 191:1137–1148.[Abstract/Full Text]

30 Hudrisier, D., J. Riond, H. Mazarguil, J.E. Gairin, and E. Joly. 2001. CTLs rapidly capture membrane fragments from target cells in a TCR signaling-dependent manner. J. Immunol. 166:3645–3649.[Abstract/Full Text]

31 Sabzevari, H., J. Kantor, A. Jaigirdar, Y. Tagya, M. Naramura, J.W. Hodge, J. Bernon, and J. Schlom. 2001. Acquisition of CD80 (B7-1) by T cells. J. Immunol. 166:2505–2513.[Abstract/Full Text]

32 Batista, F.D., D. Iber, and M.S. Neuberger. 2001. B cells acquire antigen from target cells after synapse formation. Nature. 411:489–494.[Medline]

33 Sundbäck, J., M.C. Nakamura, M. Waldenstrom, E.C. Niemi, W.E. Seaman, J.C. Ryan, and K. Karre. 1998. The 2 domain of H-2Dd restricts the allelic specificity of the murine NK cell inhibitory receptor Ly-49A. J. Immunol. 160:5971–5978.[Abstract/Full Text]

34 Matsumoto, N., R.K. Ribaudo, J.P. Abastado, D.H. Margulies, and W.M. Yokoyama. 1998. The lectin-like NK cell receptor Ly-49A recognizes a carbohydrate-independent epitope on its MHC class I ligand. Immunity. 8:245–254.[Medline]

35 Waldenström, M., J. Sundbäck, M.Y. Olsson-Alheim, A. Achour, and K. Kärre. 1998. Impaired MHC class I (H-2Dd)-mediated protection against Ly-49A⁺ NK cells after amino acid substitutions in the antigen binding cleft. Eur. J. Immunol. 28:2872–2881.[Medline]

36 Nakamura, M.C., S. Hayashi, E.C. Niemi, J.C. Ryan, and W.E. Seaman. 2000. Activating Ly-49D and inhibitory Ly-49A natural killer cell receptors demonstrate distinct requirements for interaction with H2-Dd. J. Exp. Med. 192:447–453.[Abstract/Full Text]

37 Matsumoto, N., M. Mitsuki, K. Tajima, W.M. Yokoyama, and K. Yamamoto. 2001. The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand. J. Exp. Med. 193:147–157.[Abstract/Full Text]

38 Karlhofer, F.M., R. Hunziker, A. Reichlin, D.H. Margulies, and W.M. Yokoyama. 1994. Host MHC class I molecules modulate in vivo expression of a NK cell receptor. J. Immunol. 153:2407–2416.[Abstract]

39 Kase, A., M.H. Johansson, M.Y. Olsson-Alheim, K. Kärre, and P. Höglund. 1998. External and internal calibration of the MHC class I-specific receptor Ly49A on murine natural killer cells. J. Immunol. 161:6133–6138.[Abstract/Full Text]

40 Held, W., J. Roland, and D.H. Raulet. 1995. Allelic exclusion of Ly49 family genes encoding class I-MHC-specific receptors on NK cells. Nature. 376:355–358.[Medline]

41 Brennan, J., G. Mahon, D.L. Mager, W.A. Jefferies, and F. Takei. 1996. Recognition of class I major histocompatibility complex molecules by Ly49: specificities and domain interactions. J. Exp. Med. 183:1553–1559.[Abstract]

42 Silver, E.T., D.-E. Gong, C.S. Chang, A. Amrani, P. Santamaria, and K.P. Kane. 2000. Ly-49P activates NK-mediated lysis by recognizing H-2Dd. J. Immunol. 165:1771–1781.[Abstract/Full Text]

43 Michaelsson, J., A. Achour, M. Salcedo, A. Kase-Sjöström, J. Sudback, R.A. Harris, and K. Kärre. 2000. Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers. Eur. J. Immunol. 30:300–307.[Medline]

44 Natarajan, K., L.F. Boyd, P. Schuck, W.M. Yokoyama, D. Eilat, and D.H. Margulies. 1999. Interaction of the NK cell inhibitory receptor Ly49A with H-2Dd: identification of a site distinct from the TCR site. Immunity. 11:591–601.[Medline]

45 Chung, D.H., K. Natarajan, L.F. Boyd, J. Tormo, R.A. Mariuzza, W.M. Yokoyama, and D.H. Margulies. 2000. Mapping the ligand of the NK inhibitory receptor Ly49A on living cells. J. Immunol. 165:6922–6932.[Abstract/Full Text]

46 Matsumoto, N., K. Tajima, M. Mitsuki, and K. Yamamoto. 2001. H-2 allele specificity of the NK cell C-type lectin-like MHC class I receptor Ly49A visualized by soluble Ly49A tetrAm. Int. Immunol. 13:615–623.[Abstract/Full Text]

47 Lam, K.P., R. Kuhn, and K. Rajewsky. 1997. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell. 90:1073–1083.[Medline]

48 Di Fiore, P.P., and P. De Camilli. 2001. Endocytosis and signaling: an inseparable partnership. Cell. 106:1–4.[Medline]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

This article has been cited by other articles:

• Stern-Ginossar, N., Nedvetzki, S., Markel, G., Gazit, R., Betser-Cohen, G., Achdout, H., Aker, M., Blumberg, R. S., Davis, D. M., Appelmelk, B., Mandelboim, O. (2007). Intercellular Transfer of Carcinoembryonic Antigen from Tumor Cells to NK Cells. J. Immunol. 179: 4424-4434 [Abstract] [Full Text]  
• Benoit, L. A., Tan, R. (2007). Xenogeneic beta2-Microglobulin Substitution Alters NK Cell Function. J. Immunol. 179: 1466-1474 [Abstract] [Full Text]  
• Roda-Navarro, P., Reyburn, H. T. (2007). Intercellular protein transfer at the NK cell immune synapse: mechanisms and physiological significance. FASEB J. 21: 1636-1646 [Abstract] [Full Text]  
• McCann, F. E., Eissmann, P., Onfelt, B., Leung, R., Davis, D. M. (2007). The Activating NKG2D Ligand MHC Class I-Related Chain A Transfers from Target Cells to NK Cells in a Manner That Allows Functional Consequences. J. Immunol. 178: 3418-3426 [Abstract] [Full Text]  
• Hudrisier, D., Aucher, A., Puaux, A.-L., Bordier, C., Joly, E. (2007). Capture of Target Cell Membrane Components via Trogocytosis Is Triggered by a Selected Set of Surface Molecules on T or B Cells. J. Immunol. 178: 3637-3647 [Abstract] [Full Text]  
• Back, J., Chalifour, A., Scarpellino, L., Held, W. (2007). Stable masking by H-2Dd cis ligand limits Ly49A relocalization to the site of NK cell/target cell contact. Proc. Natl. Acad. Sci. USA 104: 3978-3983 [Abstract] [Full Text]  
• Onfelt, B., Nedvetzki, S., Benninger, R. K. P., Purbhoo, M. A., Sowinski, S., Hume, A. N., Seabra, M. C., Neil, M. A. A., French, P. M. W., Davis, D. M. (2006). Structurally Distinct Membrane Nanotubes between Human Macrophages Support Long-Distance Vesicular Traffic or Surfing of Bacteria. J. Immunol. 177: 8476-8483 [Abstract] [Full Text]  
• Bourbie-Vaudaine, S., Blanchard, N., Hivroz, C., Romeo, P.-H. (2006). Dendritic Cells Can Turn CD4+ T Lymphocytes into Vascular Endothelial Growth Factor-Carrying Cells by Intercellular Neuropilin-1 Transfer. J. Immunol. 177: 1460-1469 [Abstract] [Full Text]  
• Sprent, J. (2005). Swapping Molecules During Cell-Cell Interactions. Sci Signal 2005: pe8-pe8 [Abstract] [Full Text]  
• Poupot, M., Pont, F., Fournie, J.-J. (2005). Profiling Blood Lymphocyte Interactions with Cancer Cells Uncovers the Innate Reactivity of Human {gamma}{delta} T Cells to Anaplastic Large Cell Lymphoma. J. Immunol. 174: 1717-1722 [Abstract] [Full Text]  
• Wetzel, S. A., McKeithan, T. W., Parker, D. C. (2005). Peptide-Specific Intercellular Transfer of MHC Class II to CD4+ T Cells Directly from the Immunological Synapse upon Cellular Dissociation. J. Immunol. 174: 80-89 [Abstract] [Full Text]  
• Vanherberghen, B., Andersson, K., Carlin, L. M., Nolte-`t Hoen, E. N. M., Williams, G. S., Hoglund, P., Davis, D. M. (2004). Human and murine inhibitory natural killer cell receptors transfer from natural killer cells to target cells. Proc. Natl. Acad. Sci. USA 101: 16873-16878 [Abstract] [Full Text]  
• Poupot, M., Fournie, J.-J. (2003). Spontaneous Membrane Transfer Through Homotypic Synapses Between Lymphoma Cells. J. Immunol. 171: 2517-2523 [Abstract] [Full Text]  
• Espinosa, E., Tabiasco, J., Hudrisier, D., Fournie, J.-J. (2002). Synaptic Transfer by Human {gamma}{delta} T Cells Stimulated with Soluble or Cellular Antigens. J. Immunol. 168: 6336-6343 [Abstract] [Full Text]  
• HUDRISIER, D., BONGRAND, P. (2002). Intercellular transfer of antigen-presenting cell determinants onto T cells: molecular mechanisms and biological significance. FASEB J. 16: 477-486 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF, 341K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Zimmer, J. Articles by Held, W. Search for Related Content PubMed PubMed Citation Articles by Zimmer, J. Articles by Held, W. Social Bookmarking                            What's this?